NR4A1 and breast carcinoma: A 2020 experiment in vitro showed that PPARγ, which is commonly expressed in human primary and metastatic breast cancer [218], interacted with Nur77, recruited the ubiquitin E3 enzyme Trim13 to target the ubiquitin proteasomal degradation of Nur77, and promoted breast cancer progression.